Table of Contents Table of Contents
Previous Page  86 / 86
Show Menu
Previous Page 86 / 86
Page Background – For Patients

| – For Clinicians

275 Commerce Drive

Suite 300

Fort Washington, PA 19034


NCCN Foundation


gratefully acknowledges our industry supporters Gilead Sciences, Pharmacyclics, LLC an AbbVie Company,

Teva Pharmaceuticals, and Pfizer, Inc. for their support in making available these NCCN Guidelines for Patients


. NCCN independently

develops and distributes the NCCN Guidelines for Patients. Our industry supporters do not participate in the development of the NCCN

Guidelines for Patients and are not responsible for the content and recommendations contained therein.


Version 1.2016


Guidelines for Patients


NCCN Non-HodGkin’s LymphomaS Series

Peripheral T-cell